Patient Engagement for Life Sciences Research and Development | Deloitte US has been added to your bookmarks.
Patient engagement for life sciences research and development
Opportunities and implications
Patient engagement, while a common focus for life sciences product marketing, is also growing in importance and influence for life sciences research and development (R&D). Patient engagement trends create both opportunities and implications for life sciences R&D. In this perspective, we will explore the opportunities and implications as well as identify a set of enablers that provide an approach for life sciences companies to address each opportunity and implication.
Patient engagement opportunities for life sciences R&D
This article explores patient engagement opportunities for life sciences R&D organizations. By leveraging four emerging marketplace developments, organizations can:
- Optimize their R&D pipeline by understanding disease progression via patient journey maps
- Support clinical research by accessing longitudinal health care data
- Strengthen adherence to clinical trial protocol regimens by taking advantage of new technologies (wearables and mobile apps)
- Aid patient cohort identification by accessing rich health care data
- Drive participation and improvement in clinical trial recruitment by providing new avenues for patient advocacy groups to understand clinical trials and clinical research studies
Understanding the patient engagement ecosystem
Patient engagement, while a common focus for life sciences product marketing, is also growing in importance and influence for life sciences research and development (R&D). With technology as a tool, increasing numbers of consumers (patients) are taking the lead when it comes to managing their individual health care. They are proactively researching conditions and potential treatments online (including a drug’s benefits and side effects); conferring with cohorts via social media and online communities; discussing and selecting care regimens with their physician; using new wearable technologies and mobile health (mHealth) applications; and, sometimes, taking the initiative to participate in a clinical trial and/or clinical research study.
Heightened consumer interest and activism are driving changes along the entire health care continuum, as well as the realization among life sciences companies and other stakeholders in the health care ecosystem that engaging patients in product R&D can help to improve their well-being at both the personal and population health levels.